• 05 Dec 2019

Morning Note – 5 December 2019

Evgen Pharma, 3.2 | Circassia Pharmaceuticals, 18.5

    • Mark Brewer

    • 4 pages

Biotechnology image


 
Biotechnology image


Circassia Pharmaceuticals (CIR): Corp Board changes – transition to the next phase of growth | Evgen Pharma (EVG): Corp Investigator-led study in NASH


Sign up to access

Get access to our full offering from over 30 providers

Get access to our full offering from over 30 providers


Get Started
Already a member? Log in here

More Content

More Content

Morning Note – 13 February 2020

Companies: FLO LID EVG ONC

Riccardo Lowi discusses Evgen Pharma

Companies: Evgen Pharma

SP Angel Healthcare Conditions

Companies: DNL LID EVG

Circassia Pharmaceuticals' commercial development 'accelerating significantly'

Companies: Circassia Pharmaceuticals

SP Angel Healthcare Conditions

Companies: Evgen Pharma

Copyright © 2020 Research Tree | All Rights Reserved. | Terms of Service and Privacy Policy and Statement on Cookies

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Tools licensed and contents implemented and optimized by Digital Look Ltd.

DigitalLook |Web Financial Group

©1999-2013 – Digital Look Ltd. A Web Financial Group Company All rights reserved. Legal notice.

Top